Abiopharma

(10% Negative) SYNDAX PHARMACEUTICALS, INC. (SNDX) Announces Delay in time Trials for areas of clear unmet need Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(19% Negative) Cytokinetics, Incorporated (CYTK) Announces Delay in Specified Development Timeline Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(80% Positive) OPTINOSE, INC. (OPTN) Announces Clinical Development Update

(10% Negative) Sage Therapeutics, Inc. (SAGE) Announces Clinical Trial Timeline Adjustment

(10% Negative) IMAGO BIOSCIENCES, INC. (IMGO) Announces Delay in path Development Timeline Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(99% Neutral) Grifols (GRFS) Announces 2022 Annual General Meeting

(99% Neutral) ABSCI CORP (ABSI) Files Form 8-K

(99% Neutral) QUANTUM-SI INCORPORATED (QSI) Announces New Board Appointment

(99% Neutral) BOLT BIOTHERAPEUTICS, INC. (BOLT) Files Form 8-K

(99% Neutral) CORTEXYME, INC. (CRTX) Announces New Board Appointment